These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33244474)

  • 1. Classification of Manifest Huntington Disease using Vowel Distortion Measures.
    Romana A; Bandon J; Carlozzi N; Roberts A; Provost EM
    Interspeech; 2020 Oct; 2020():4966-4970. PubMed ID: 33244474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H; Bohlen S; Saft C; Hoffmann R; Gerss J; Muratori L; Ringelstein EB; Landwehrmeyer GB; Reilmann R
    Gait Posture; 2018 May; 62():451-457. PubMed ID: 29660633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phonatory dysfunction as a preclinical symptom of Huntington disease.
    Rusz J; Saft C; Schlegel U; Hoffman R; Skodda S
    PLoS One; 2014; 9(11):e113412. PubMed ID: 25409322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages.
    Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J
    Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.
    Vinther-Jensen T; Larsen IU; Hjermind LE; Budtz-Jørgensen E; Nielsen TT; Nørremølle A; Nielsen JE; Vogel A
    Orphanet J Rare Dis; 2014 Jul; 9():114. PubMed ID: 25026978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
    Lipsmeier F; Simillion C; Bamdadian A; Tortelli R; Byrne LM; Zhang YP; Wolf D; Smith AV; Czech C; Gossens C; Weydt P; Schobel SA; Rodrigues FB; Wild EJ; Lindemann M
    J Med Internet Res; 2022 Jun; 24(6):e32997. PubMed ID: 35763342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Language disintegration in spontaneous speech in Huntington's disease: a more fine-grained analysis.
    Tovar A; Garí Soler A; Ruiz-Idiago J; Mareca Viladrich C; Pomarol-Clotet E; Rosselló J; Hinzen W
    J Commun Disord; 2020; 83():105970. PubMed ID: 32062158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
    Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
    Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease.
    Adjeroud N; Besnard J; Verny C; Prundean A; Scherer C; Gohier B; Bonneau D; Massioui NE; Allain P
    Neuropsychologia; 2017 Aug; 103():87-95. PubMed ID: 28712946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington's Disease.
    Achenbach J; Matusch A; Elmenhorst D; Bauer A; Saft C
    Biomedicines; 2022 May; 10(6):. PubMed ID: 35740281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
    Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
    J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease.
    Reyes A; Bartlett DM; Rankin TJ; Zaenker P; Turner K; Teo WP; Fu SC; Domingos J; Georgiou-Karistianis N; Ziman M; Cruickshank TM
    Phys Ther; 2021 Apr; 101(4):. PubMed ID: 33482001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Pathophysiology of Apathy in Huntington Disease: A Systematic Review and Meta-Analysis.
    Abdollah Zadegan S; Coco HM; Reddy KS; Anderson KM; Teixeira AL; Stimming EF
    J Neuropsychiatry Clin Neurosci; 2023; 35(2):121-132. PubMed ID: 36353818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital assessment of speech in Huntington disease.
    Nunes AS; Pawlik M; Mishra RK; Waddell E; Coffey M; Tarolli CG; Schneider RB; Dorsey ER; Vaziri A; Adams JL
    Front Neurol; 2024; 15():1310548. PubMed ID: 38322583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
    Paulsen JS; Long JD; Johnson HJ; Aylward EH; Ross CA; Williams JK; Nance MA; Erwin CJ; Westervelt HJ; Harrington DL; Bockholt HJ; Zhang Y; McCusker EA; Chiu EM; Panegyres PK;
    Front Aging Neurosci; 2014; 6():78. PubMed ID: 24795630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB
    Ceccarini J; Ahmad R; Van de Vliet L; Casteels C; Vandenbulcke M; Vandenberghe W; Van Laere K
    J Nucl Med; 2019 Jan; 60(1):115-121. PubMed ID: 29934407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two different phenomena in basic motor speech performance in premanifest Huntington disease.
    Skodda S; Grönheit W; Lukas C; Bellenberg B; von Hein SM; Hoffmann R; Saft C
    Neurology; 2016 Apr; 86(14):1329-1335. PubMed ID: 26962067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.